Clinical Trial Update: Decitabine and Anti-PD-1 in R/R DLBCL [Phase 2]

View source ↗

Summary

Phase 2 trial investigating decitabine in combination with anti-PD-1 for relapsed/refractory diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Anti-PD-1
• Decitabine (Decitabine)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Diffuse Large B Cell Lymphoma, Relapse/Recurrence | Phase 2 | Status: UNKNOWN